Ovid Therapeutics is partnering with privately held biotechnology startup Graviton Bioscience to develop drugs for rare brain disorders with few or no other treatment options.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,